Komori
Miahelsa Holdings (7129) · RiskMaterialised

Dependence on Prescription-Issuing Medical Institutions and Prescription Declines Driven by Competition

First written in FY2025. 2 of 3 entries say "Materialised", first in FY2026. Latest entry: 2026-08-10.

3entries
2years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2025MaterialisedFY2026 – 2026-08-102025: 120252026: 22026
Same theme, other companies
Business Dependence on Medical Institutions and Prescription TrendsA theme 2 companies write about · 2 as a headwind · 0 as a tailwind

Miahelsa Holdings moved to the "Worse" side of this theme in 2026.

0 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. 2026-08-10MaterialisedFinancial Results Presentation

    「Large-hospital clinic-front pharmacies △4,247 prescriptions (impact of reverse referrals*)」

    The number of prescriptions at clinic-front pharmacies declined year on year due to the impact of reverse referrals from large hospitals. Overall prescription volume increased, however, due to the increase in medical-mall pharmacies.
  2. FY2026MaterialisedAnnual report

    「Although the number of prescriptions handled by pharmacies located near hospitals declined due to reverse referrals by university hospitals, the increase in prescriptions resulting from the effect of new store openings led to a result exceeding that of the previous consolidated fiscal year.」

    The company stated that the number of prescriptions handled by pharmacies located near hospitals actually declined due to reverse referrals by prescribing medical institutions. However, the effect of new store openings more than offset the decline, resulting in an overall increase in prescriptions.
  3. FY2025First statedAnnual report

    「Pharmaceutical business sales depend heavily on medical institutions that issue prescriptions, and trends at medical institutions with high prescription fulfillment rates, as well as their suspension or closure, could affect the group’s results.」

    The company separately disclosed the risk that its high dependence on medical institutions issuing prescriptions, changes at or closures of medical institutions, and the opening of competing pharmacies could reduce customer numbers and results.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Miahelsa Holdings yet. It last moved in the Financial Results Presentation of 2026-08-10: "Materialised".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Dependence on Prescription-Issuing Medical Institutions and Prescription Declines Driven by Competition | Miahelsa Holdings Corporation (7129) | Komori